EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer

Ling Qi, Li Wang, Mengru Jin, Mingxia Jiang, Lisha Li, Yanjing Li iD

Immunology · 2023

DOI: 10.1111/imm.13633 ↗

At a glance

Übersichtsarbeit in Immunology, 2023. Written by Ling Qi and 5 co-authors. Institution: Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Major MEDLINE topics: Apoptosis, Neoplasms. Cited 41 times so far (Crossref); 114 references. Funded by: Wu Jieping Medical Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Cysteinyl aspartate specific proteinase (caspase)‐6 belongs to the caspase family and plays a vital role in mediating cell death. Under certain conditions, three pathways of programmed cell death (PCD), including apoptosis, necroptosis and pyroptosis (PANoptosis), transform one way into another, with enormous therapeutic potential. Initially, scholars reported that caspase‐6 is a caspase executor that mediates apoptosis. With the ceaseless exploration of the PCD types, studies have demonstrated that caspase‐6 mediates pyroptosis by regulating gasdermin D and mediates necroptosis by regulating mixed lineage kinase domain‐like. By regulating PANoptosis, caspase‐6 plays a crucial role in tumorigenesis in humans and mediates anti‐tumour immunity. Therefore, a comprehensive understanding of caspase‐6 function in cancer via PANoptosis is important for the prevention and therapy of tumours. This article summarized the function of caspase‐6 in PANoptosis and its impact on cancer development, providing targets and strategies for tumour treatment.

Subjects

MeSH terms (MEDLINE)

ApoptosisNeoplasmsHumansCaspase 6PyroptosisCaspasesCaspase 8

Author keywords

PANoptosisapoptosiscancercaspase-6necroptosispyroptosis

Substances

Caspase 6CaspasesCaspase 8

Authors and institutions

  • Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
  • Department of Medical Oncology, the Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China.
  • Department of Medical Oncology, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID profiles: Yanjing Li

Funding

  • Wu Jieping Medical Foundation

Cite

APA

Qi, L., Wang, L., Jin, M., Jiang, M., Li, L., & Li, Y. (2023). Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer. Immunology. https://doi.org/10.1111/imm.13633

Vancouver

Qi L, Wang L, Jin M, Jiang M, Li L, Li Y. Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer. Immunology. 2023. doi:10.1111/imm.13633

BibTeX
@article{Qi2023,
  author = {Qi, Ling and Wang, Li and Jin, Mengru and Jiang, Mingxia and Li, Lisha and Li, Yanjing},
  title = {Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer},
  journal = {Immunology},
  year = {2023},
  doi = {10.1111/imm.13633}
}
Start for free →